BMRA — Biomerica Cashflow Statement
0.000.00%
Last trade - 00:00
- $12.28m
- $6.97m
- $5.34m
- 14
- 32
- 39
- 18
2019 May 31st | 2020 May 31st | 2021 May 31st | R2022 May 31st | 2023 May 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -2.39 | -2.34 | -6.47 | -4.53 | -7.14 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0.173 | 0.486 | 2.93 | 0.113 | 1.62 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.197 | -2.57 | -1.85 | 3.6 | -0.038 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -2.24 | -4.3 | -5.25 | -0.479 | -5.47 |
Capital Expenditures | -0.171 | -0.119 | -0.296 | -0.17 | -0.078 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Cash from Investing Activities | -0.171 | -0.119 | -0.296 | -0.17 | -0.078 |
Financing Cash Flow Items | 0.009 | — | — | -0.085 | -0.705 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 1.91 | 12.4 | 1.11 | 2.39 | 9.39 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.518 | 7.95 | -4.44 | 1.72 | 3.8 |